TOP TIERMARKET NEWSWIRE

News & sentiment

ARBUTUS BIOPHARMA CO (ABUS) — News & AI sentiment

ARBUTUS BIOPHARMA CO (ABUS) news roundup. 5 stories in the past week, 12 over 30 days. Average 30-day sentiment is 61/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

5

avg sentiment 67/100

30d stories

12

avg sentiment 61/100

Insider net (90d)

$0

0 buys · 0 sells

Congress (90d)

0

0 buys · 0 sells

ABUS news in the last 24 hours, 7 days, 30 days and 90 days

How much ABUS coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	ABUS stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	5	67/100	ABUS headlines →
Last 30 days	12	61/100	ABUS headlines →
Last 90 days	32	58.9/100	ABUS headlines →

Latest stories on ABUS

Why is Arbutus Biopharma stock climbing today?

Investing.com Markets63 · neutralgeneral

6d ago

FDA lifts clinical hold on Arbutus Biopharma AB-101 IND application

The Fly74 · bullishproduct/pr

6d ago

Arbutus Biopharma Corp (ABUS) files 8-K

SEC 8-K50 · neutralgeneral

6d ago

Arbutus Announces FDA Clinical Hold is Lifted on IND Application for AB-101, an Oral PD-L1 Inhibitor

GlobeNewswire74 · bullishproduct/pr

6d ago

Arbutus Announces FDA Clinical Hold is Lifted on IND Application for AB-101, an Oral PD-L1 Inhibitor

Business Insider74 · bullishproduct/pr

6d ago

Arbutus Biopharma: $230M Buyback And Moderna Cash De-Risk The Path To A Potential HBV Cure

Seeking Alpha67 · bullishgeneral

Oct 8

Arbutus Announces Final Results of Its US$230 Million Modified “Dutch Auction” Tender Offer

Business Insider48 · neutralgeneral

Oct 1

Arbutus Announces Final Results of Its US$230 Million Modified “Dutch Auction” Tender Offer

GlobeNewswire48 · neutralgeneral

Oct 1

Arbutus gains on plans to buy back 46M shares in tender offer

Seeking Alpha71 · bullishgeneral

Sep 30

ABUS shares trade near $4.89 after tender offer sets preliminary purchase price at $5.00 for 46 million shares September 30, 2026

MarketChameleon71 · bullishgeneral

Sep 30

Arbutus Announces Preliminary Results of Its US$230 Million Modified “Dutch Auction” Tender Offer

GlobeNewswire42 · neutralgeneral

Sep 30

Arbutus Announces Preliminary Results of Its US$230 Million Modified “Dutch Auction” Tender Offer

Business Insider50 · neutralgeneral

Sep 30

Chronic Hepatitis B Market Statistics Expected to Experience Major Growth by 2034, According to DelveInsight | Gilead Sciences, GlaxoSmithKline, Ionis Pharma, Precision Biosciences, Silverback Thera

Barchart63 · neutralgeneral

Sep 12

Arbutus Biopharma commences $230M modified Dutch Auction tender offer

The Fly24 · bearishgeneral

Aug 24

Arbutus Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share

GlobeNewswire24 · bearishgeneral

Aug 24

Arbutus Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share

Business Insider28 · bearishgeneral

Aug 24

Arbutus Biopharma Commits to Up to $230 Million Share Buyback With Dutch Auction Tender—What Does It Mean for Investors?

MarketChameleon71 · bullishgeneral

Aug 21

Arbutus Biopharma Shares Rise on $230 Million Stock Buyback

MarketWatch71 · bullishgeneral

Aug 21

Why is Arbutus Biopharma stock surging today?

Investing.com Markets65 · bullishgeneral

Aug 21

Arbutus Biopharma shares jump after unveiling $230 million share buyback plan

InvestorsHub71 · bullishgeneral

Aug 21

ABUS Stock Surges 10% Today — What’s Driving This Super Rally?

Stocktwits News71 · bullishgeneral

Aug 21

Arbutus Biopharma Corp (ABUS) files 8-K

SEC 8-K50 · neutralgeneral

Aug 21

Arbutus Plans Up to $230 Million Share Buyback via Dutch Auction—What Does This Mean for Shareholders? August 21, 2026

MarketChameleon71 · bullishgeneral

Aug 21

Arbutus Biopharma to repurchase $230M of shares through Dutch Auction

The Fly71 · bullishgeneral

Aug 21

Arbutus to repurchase up to $230M of shares in tender offer

Seeking Alpha71 · bullishgeneral

Aug 21

Open ABUS in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →